首页 | 本学科首页   官方微博 | 高级检索  
     


Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease
Authors:Lodewijk de Groot  Helmy Hinkema  Johanna Westra  Andries J Smit  Cees GM Kallenberg  Marc Bijl  Marcel D Posthumus
Affiliation:(1) Department of Rheumatology and Clinical Immunology, University Medical Centre, University of Groningen, Groningen, The Netherlands;(2) Department of Vascular Disease, University Medical Centre, University of Groningen, Groningen, The Netherlands
Abstract:

Introduction  

Advanced glycation end products (AGEs) are produced and can accumulate during chronic inflammation, as might be present in patients with rheumatoid arthritis (RA). AGEs are involved in the development of cardiovascular disease. The aim of this study is to evaluate whether AGEs are increased in patients with long-standing RA and whether AGE accumulation is related to disease activity, disease severity and measures of (premature) atherosclerosis, such as endothelial activation, endothelial dysfunction and intima media thickness (IMT).
Keywords:rheumatoid arthritis   endothelial cell activation   endothelial dysfunction   intima media thickness   advanced glycation end products   atherosclerosis
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号